Lung Cancer Screening for Individuals in Tampa, FL
If you’re a current or former smoker who lives or works in the Tampa, Florida, area, lung cancer screening at Moffitt Cancer Center could potentially save your life. That’s because our highly effective screening tests can often detect precancerous cellular changes before those changes produce symptoms or progress into cancer. Many studies show that patients who are diagnosed with early-stage lung cancer usually have better outcomes and quality of life than those who are diagnosed after their cancer has reached an advanced stage.
Lung cancer screening is important not only for tobacco users, but also for anyone who has a family history of lung cancer or has been exposed to secondhand smoke, radon, asbestos or other carcinogens. Individuals who are concerned about their risk level can meet with an experienced pulmonologist at Moffitt in Tampa, FL, for a personal assessment and individualized guidance.
In general, Moffitt’s comprehensive lung cancer screening program is appropriate for individuals who are:
- Between the ages of 50 and 77
- Current or former smokers with a 20-pack year smoking history (pack year = total # of years smoked X # of packs smoked per day)
- Are referred to the program by a general physician or pulmonologist
In addition to peace of mind, participants in Moffitt’s lung cancer screening program – which ranks among the best in the nation – can experience several benefits. These include high-definition CT scans, a prompt multispecialty tumor board review of test results, preferential appointments with oncologists who specialize in treating lung cancer and access to smoking cessation programs and other supportive services.
Individuals in Tampa, FL, who are interested in learning more about Moffitt’s lung cancer screening program can call 1-888-663-3488 or complete a new patient registration form online.
Lung Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer